SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-23-000463
Filing Date
2023-01-20
Accepted
2023-01-20 16:08:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D gsk_sc13da-110722.htm SC 13D/A 21381
  Complete submission text file 0001387131-23-000463.txt   23280
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 23541049
SIC: 2834 Pharmaceutical Preparations